Literature DB >> 6244565

Mutant and recombinant avian retroviruses with extended host range.

P N Tsichlis, K F Conklin, J M Coffin.   

Abstract

Avian retroviruses of subgroups B and D efficiently infect chicken (C/E) but not turkey (T/BD) cells. We describe here three variants of subgroup B and D viruses that infect both cell types equally well. One of these viruses, NTRE-4, was a recombinant between transformation-defective Prague (Pr) strain Rous sarcoma virus (RSV) subgroup B and the endogenous virus RAV-0; the second, SR-DE-1, was a recombinant between Schmidt-Ruppin RSV subgroup D and defective endogenous virus information. T1 oligonucleotide fingerprint analysis of the genomes of these two viruses showed only a small alteration in the portion of the env gene responsible for subgroup specificity, as indicated by the presence of a single subgroup E oligonucleotide in an otherwise purely subgroup B or D gene. The third virus, hrBO1Pr-B, was a variant of Pr-RSV-B that did not appear to be a recombinant and whose altered host range we attribute to mutation. Analysis of the host range of all three viruses by infection of selectively resistant cells and by interference testing indicates that all use the subgroup B receptor on chicken cells and the subgroup E receptor on turkey cells. These viruses may be analogous to the polytropic recombinant viruses recently found to be associated with leukemia in some strains of mice.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6244565      PMCID: PMC348307          DOI: 10.1073/pnas.77.1.536

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  The role of the tvb locus in genetic resistance to RSV(RAV-O).

Authors:  L B Crittenden; J V Motta
Journal:  Virology       Date:  1975-10       Impact factor: 3.616

2.  A physical map of the Rous sarcoma virus genome.

Authors:  J M Coffin; M A Billeter
Journal:  J Mol Biol       Date:  1976-01-25       Impact factor: 5.469

3.  Infection of chick cells by subgroup E viruses.

Authors:  M Linial; P E Neiman
Journal:  Virology       Date:  1976-09       Impact factor: 3.616

4.  Nucleotide sequence relationships between the genomes of an endogenous and an exogenous avian tumor virus.

Authors:  J M Coffin; M Champion; F Chabot
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

5.  The nucleotide sequence complexity of avian tumor virus RNA.

Authors:  M A Billeter; J T Parsons; J M Coffin
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

6.  DEAE-dextran: enhancement of cellular transformation induced by avian sarcoma viruses.

Authors:  P K Vogt
Journal:  Virology       Date:  1967-09       Impact factor: 3.616

7.  Mapping of biological functions on RNA of avian tumor viruses: location of regions required for transformation and determination of host range.

Authors:  R H Joho; M A Billeter; C Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

8.  Intracellular restriction on the growth of induced subgroup E avian type C viruses in chicken cells.

Authors:  H L Robinson
Journal:  J Virol       Date:  1976-06       Impact factor: 5.103

9.  A new class of murine leukemia virus associated with development of spontaneous lymphomas.

Authors:  J W Hartley; N K Wolford; L J Old; W P Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

10.  Amphotropic host range of naturally occuring wild mouse leukemia viruses.

Authors:  S Rasheed; M B Gardner; E Chan
Journal:  J Virol       Date:  1976-07       Impact factor: 5.103

View more
  20 in total

1.  Point mutations in the avian sarcoma/leukosis virus 3' untranslated region result in a packaging defect.

Authors:  J M Aschoff; D Foster; J M Coffin
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes.

Authors:  P Westervelt; H E Gendelman; L Ratner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

3.  Evolution of broad host range in retroviruses leads to cell death mediated by highly cytopathic variants.

Authors:  G Jonah A Rainey; John M Coffin
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Selection of an avian retrovirus mutant with extended receptor usage.

Authors:  R A Taplitz; J M Coffin
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  Model of the TVA receptor determinants required for efficient infection by subgroup A avian sarcoma and leukosis viruses.

Authors:  Deborah C Melder; Gennett M Pike; Matthew W VanBrocklin; Mark J Federspiel
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

6.  Identification of key residues in subgroup A avian leukosis virus envelope determining receptor binding affinity and infectivity of cells expressing chicken or quail Tva receptor.

Authors:  S L Holmen; D C Melder; M J Federspiel
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

7.  Molecular basis of host range variation in avian retroviruses.

Authors:  A J Dorner; J P Stoye; J M Coffin
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

8.  Evolutionary pressure of a receptor competitor selects different subgroup a avian leukosis virus escape variants with altered receptor interactions.

Authors:  Deborah C Melder; V Shane Pankratz; Mark J Federspiel
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Specificity of avian leukosis virus-induced hyperlipidemia.

Authors:  J K Carter; R E Smith
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

10.  Large RNase T1-resistant oligonucleotides encoding p15E and the U3 region of the long terminal repeat distinguish two biological classes of mink cell focus-forming type C viruses of inbred mice.

Authors:  M L Lung; J W Hartley; W P Rowe; N H Hopkins
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.